Be part of the knowledge.™

Pediatrics

411

LikeLikedUnlike

16-30 of 33

Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
MinuteCE®
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
MinuteCE®
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
MinuteCE®
Pediatric Narcolepsy: How to Address Its Burden of Illness Through Prompt Recognition, Diagnosis, and Management
- Kiran Maski, MD, MPH
  Peer
- Funke Afolabi-Brown, MD
  Peer
- Anne M. Morse, DO
  Peer
1.00 credits 10 episodes
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
MinuteCE®
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
- Funke Afolabi-Brown, MD
  Peer
1.00 program credits
Narcolepsy’s Burden of Illness: Its Impact on the Child and Family
MinuteCE®
Narcolepsy’s Burden of Illness: Its Impact on the Child and Family
- Anne M. Morse, DO
  Peer
1.00 program credits
Pediatric Narcolepsy: Physical Comorbidities
MinuteCE®
Pediatric Narcolepsy: Physical Comorbidities
- Kiran Maski, MD, MPH
  Peer
1.00 program credits
advertisement
Pediatric Narcolepsy: Psychological and Social Comorbidities
MinuteCE®
Pediatric Narcolepsy: Psychological and Social Comorbidities
- Kiran Maski, MD, MPH
  Peer
1.00 program credits
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
- Anne M. Morse, DO
  Peer
1.00 program credits
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
- Funke Afolabi-Brown, MD
  Peer
1.00 program credits
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CE
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
- Omer Abdul Hamid, MD
  Peer
- Nancy Kuntz, MD
  Peer
- Migvis Monduy, MD
  Peer
0.25 credits
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 credits 4 episodes
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
advertisement
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended